Filing Flows

Filing Flows › SeaStar Medical Holding (ICU) › Q3 2025

SeaStar Medical Holding (ICU) Q3 2025 earnings results (third quarter 2025)

10-Q filed Nov 13, 2025

SeaStar Medical Holding (ICU) reported revenue of $183K for the third quarter 2025 (Q3 2025), +169% from a year earlier and -46% from the quarter before.

Revenue$183K
Year over year+169%
Quarter over quarter-46%
Operating margin—
Net earnings−$3.5M

SeaStar Medical Holding, Q3 2025: revenue $183K (+169% year over year), net loss $3.5M, operating cash flow −$3.8M. The chart follows the revenue to costs, profit and cash.

Q3 2025AmountQ/QY/Y
Revenue$183K-46%+169%
Operating profit−$3.6M——
Net earnings−$3.5M——
Operating cash flow−$3.8M——

What changed

Revenue was $183K in Q3 2025, up 169% year over year and down 46% from the previous quarter.

Gross margin was 92.3%, down 7.7 points from a year earlier. Operating costs exceeded revenue by $3.6M, an operating margin of -1955.7%. Operating expenses fell 17% while revenue rose 169%. The quarter ended with a net loss of $3.5M, wider than the previous quarter's $2.0M loss.

Operating cash flow was −$3.8M. Non-cash charges added back $290K of share-based compensation. Working capital and other items used $662K.

Questions

What was SeaStar Medical Holding's revenue in the third quarter 2025?

SeaStar Medical Holding (ICU) reported revenue of $183K for the third quarter 2025 (Q3 2025), +169% from a year earlier and -46% from the quarter before.

Open the interactive Sankey →

Source: SeaStar Medical Holding 10-Q on SEC EDGAR.